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ABSTRACT 
Objective: To synthesize, characterize and evaluate starch crotonate as a superdisintegrant in the formulation of Piroxicam fast dissolving tablets 
by employing 23 factorial design. 
Methods: Starch crotonate was synthesized and its physical and micromeritic properties were performed to evaluate it. The fast dissolving tablet of 
Piroxicam were prepared by employing starch crotonate as a superdisintegrant in different proportions in each case by direct compression method 
using 23 factorial design. 
Results: The starch chrotonate prepared was found to be fine, free flowing and amorphous. Starch crotonate exhibited good swelling in water with 
swelling index (50%). The study of starch crotonate was shown by fourier transform infrared spectra (FTIR). The drug content (100±5%), hardness 
(3.6–4 kg/sq. cm), and friability (<0.15%) have been effective with regard to all the formulated fast dissolving tablets employing starch crotonate. 
The disintegration time of all the formulated tablets was found to be in the range of 18±03 to 66±03 sec. The optimized formulation F8 had the least 
disintegration time i.e., 18±03 sec. The wetting time of the tablets was found to be in the range of 49.92±0.11 to 140±0.18s. The In vitro wetting time 
was less (i.e., 74±0.37s) in optimized formulation F8. The water absorption ratio of the formulated tablets was found to be in the range of 
27.58±0.01 to 123.07±0.33%. The percent drug dissolved in the optimized formulation F8 was found to be 99.83% in 10 min. 
Conclusion: Starch crotonate, when combined with sodium starch glycolate, croscarmellose sodium, with Piroxicam was found to be an effective 
super disintegrant which improved the dissolution efficiency and could therefore be used in the formulation of quick dissolvi ng tablets to provide 
immediate release of the contained drug within 10 min. 
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INTRODUCTION 
Drug delivery systems (DDS) have been a strategic tool for expanding 
markets/indications, extending product life cycles and generating 
opportunities [1]. Science and technology advances have resulted in 
the development of a various novel drug delivery systems that were 
proven to be successful in delivering drugs to the target site. Patient 
compliance is one of the main issues in pharmacy practise [2]. In this 
case, solid dosage forms were assumed to provide better drug delivery 
and less side effects, as well as the ability to self-medicate, which is one 
of the most significant features of this type of dosage form. Tablets and 
capsules were the most commonly used solid dosage types, with 
difficulty in swallowing being one of the main concerns 
with their usage. This triggered further research into how to change 
these dosage types, leading to the development of Fast Dissolving 
Tablets (FDT) [3]. These were tablets that the patient can administer 
without needing to drink water. According to reports, the acceptance 
rate of FDTs had risen in recent years. 
The most interesting aspect was the rapidity with which numerous 
FDTs have been formulated in recent years using superdisintegrants 
[4]. It was true that the majority of prescription dosage forms were 
taken orally. Oral routes of drug administration have wide 
acceptance up to 50-60% of total dosage forms, with the downside 
that certain medications have a bitter taste, which affects patient 
compliance [5]. As a result, there was an urgent need to mask the 
taste of these bitter medications, leading pharmaceutical companies 
to invest time, money, and valuable resources in the creation of 
palatable and pleasant-tasting products that improved patient 
compliance. The rapid breakdown or fast disintegrating tablet 
was intended to disaggregate in the mouth on contact with saliva in 
less than 60 sec, preferably in less than 40 sec, creating an easy-to-
swallow suspension. It's generally referred to as "oral disintegrating 
tablets" (ODT), melt-in mouth tablets, rapimelts, porous tablets, 
quick dissolving etc [6].  
There were several benefits to FDTs, which have been proven to be 
more effective in drug delivery than other dosage forms. These 
dosage forms were better than Effervescent tablets or granules since 
they used less water. ODT drugs have been developed for a number 
of indications, like migraines, depression, and schizophrenia [7]. 
According to one study, elderly people have trouble chewing tablets 
and feel bitter taste, which had been a major concern in the case of 
geriatric and paediatric patients for decades. Recently the bitterness 
of these products had been reportedly decimated using varied 
flavours, sweeteners and amino acids [8].  
Utilisation of recently developed taste masking and product creation 
techniques such as freeze drying, spray drying, tablet moulding, 
sublimation, and disintegration had made it possible to produce novel 
pharmaceutical products with pleasant taste and high patient 
compliance. Many pharmacists find this to be a big challenge [9]. 
FDTs can effectively deliver high molecular weight protein and peptides 
to the targeted site. As a result, FDTs help in eliminating the concern 
about the supply of water for swallowing a dosage form, making these 
dosage forms a breakthrough in pharmaceutical research [10]. 
The advantages of fast dissolving drug delivery system include 
features like ease of administration to the patient who cannot 
swallow, such as paediatric, geriatric and psychiatric patients, no 
need of water to swallow the dosage form, which is highly 
convenient feature for patients who were traveling and do not have 
immediate access to water, accurate dose was consumed, masks the 
bitter taste of the drug so it was convenient for paediatric to swallow 
the tablet, the drug was dissolved within 15 sec and rapid onset of 
action and bioavailability of drugs was increased [11]. 
Even though there were several advantages of fast dissolving tablets 
there were certain limitations of fast Dissolving Tablets (FDT) like 
these tablets would leave unpleasant taste if not prepared properly, 
drugs which constitute large doses were tedious to formulate into 
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FDT and patients who administered anticholinergic medications 
would reportedly not to be the best candidates for FDT [12]. 
Piroxicam; a potent anti-inflammatory drug used in the treatment of 
osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and 
acute gout disease. It had prolonged the half-life of about 45 h [13]. 
The main objective of this work was to formulate and characterize 
fast dissolving tablets of Piroxicam fast dissolving tablets employing 
starch crotonate–a novel superdisintegrant, and also sodium starch 
glycolate, crospovidone as superdisintegrants by using optimization 
techniques. A 2 factorial method was used to analyse the primary 
and interaction effects of the three formulation variables, i.e. starch 
crotonate (A), starch sodium glycolate (B) and Crospovidone(C), in 
each case to identify a solution with less disintegration period and 
more percent released within 10 min and to allow for random 
collection of tablets with imminent removal within 20 min.  
MATERIALS AND METHODS 
Materials 
Crotonic acid, potato starch, Piroxicam, Crosspovidone, Sodium starch 
glycolate were obtained from Yarrow chem. Products, Mumbai. Sodium 
hydroxide, Mannitol were bought from Finar chemicals Ltd, Ahmedabad. 
Distilled water was prepared in laboratory. Starch Crotonate processed 
in the laboratory have been used. Microcrystalline cellulose was bought 
from Qualigens fine chemicals, Mumbai. Stearate of magnesium and talc 
were purchased from Molychem, Mumbai. 
Preparation of starch crotonate (a novel Superdisintegrant) 
Initially, dissolve 10 g of crotonic acid in 10 ml of distilled water, 
then add 10 g of potato starch in 25 ml of distilled water. Both were 
constantly stirred for 30 min. Using 0.1N NaOH, raise the pH to 3.5 
and stir for 16 h at 25 °C. To extract unreacted crotonic acid, it was 
purified and washed with distilled water after 16 h. Then the 
product was kept in the oven at 60ᵒc. The products obtained was 
ground and sieved [14]. 
Characterization of starch crotonate 
The prepared starch crotonate was evaluated for the following 
Solubility 
Solubility of starch crotonate was tested in water, aqueous pH 
buffers 1, 2, 3, 4, 5, 6 and 7 and inorganic solvents such as alcohol, 
dichloromethane, chloroform, acetone and petroleum ether [15]. 
pH 
The pH of 1 % w/v of slurry was visualized [15]. 
Melting point 
The Melting point was measured using the melting point apparatus [15]. 
Viscosity 
Viscosity of 1% dispersion in samples was analysed using the 
Ostwald Viscometer [15]. 
Swelling index 
Starch crotonate (200 mg) was added to 10 ml of water and light 
liquid paraffin taken in two different graduated and mixed test 
tubes. The dispersion in the tubes was permitted to stay for 12 h 
[15]. The sediment volumes in the tubes have been documented. The 
swelling index of the material was calculated as follows.  
S. I (%) =  X 100 
Test for gelling property 
The gelling properties of starch and starch crotonate were prepared 
and evaluated by heating a 7% w/v dispersion of each in water at 
100 °C for 30 min [15]. 
Particle size 
Particle size research was conducted using standard sieves for 
sifting [15]. 
Density 
Density (g/cc) was determined by the method of liquid displacement 
using benzene as liquid [15]. 
Bulk density 
Bulk density (g/cc) calculated by three type of tap in a graded 
cylinder [15]. 
Angle of repose 
The angle of the repose was calculated by a set funnel method [15]. 
Compressibility index 
Compressibility index (CI) was determined by measuring the initial 
volume (V0) and final volume (V) after hundred tapings of a sample 
of potato starch in a measuring cylinder [15]. CI had been 
determined using the equation 
Compressibility index (CI) =  X 100 
Where Vo= Initial volume, V= Final volume 
Fourier transform infrared (FTIR) spectroscopy 
FTIR spectra starch Crotonate were reported on samples prepared 
in potassium bromide (KBr) disks using BRUKER FT–IR (Tokyo, 
Japan). Samples were prepared in (KBr) disks by hydrostatic press 
at a pressure of 6-8 tonnes [15]. 
Ester test 
To 1 mg of Starch crotonate, 2 m of ethanol and 1 ml of 0.1 ml of 
NaOH were added. A phenolphthalein indicator was added to this. 
The shift of colour had been observed [15].  
Drug–excipients compatibility studies 
The compatibility of starch crotonate with the selected drug 
(Piroxicam) was evaluated in FTIR [15]. 
Infrared spectroscopy 
FTIR spectra of piroxicam, and their mixtures (1: 1) with starch 
Crotonate were recorded on a Perkin Elmer, IR Spectrophotometer 
model: Spectrum RXI, using KBr disc as reference [15]. 
Preparation of piroxicam fast dissolving tablets 
The tablets have been prepared using a direct compression process. 
The composition of the different formulations of fast-dissolving 
piroxicam tablets was shown in table 5.1. To ensure consistency in 
the particle size, each ingredient was passed through the #100 mesh 
screen before mixing. Starch Crotonate, Crospovidone, sodium 
glycolate starch and mannitol and microcrystalline cellulose was 
carefully weighed and combined with mortar and pestle and then 
added to piroxicam. In the end, talc and magnesium stearate have 
been added to the powder. The slurry was finally compressed using 
eight station rotary press [16] (Shakthi Machineries Pvt. Ltd., 
Ahmedabad, India). 
Evaluation of piroxicam fast dissolving tablets 
Hardness 
The hardness of the tablet, which seems to be the force needed to 
divide the tablet with a diametrical compression force. The hardness 
tester used in the analysis was Monsanto hardness tester, which 
needs to be applied force to the tablet diametrically with the help of 
an inbuilt spring and expressed in kg/cm [17]. 
Uniformity of weight 
The Weight variance study was conducted with 20 tablets. It was an 
actual tablet weight deviation from the average weight of 20 tablets [17]. 
Average tablet weight % Deviations 
80 mg or below ±10 
Over 80 mg or less than 250 mg ±7.5 
250 mg or less ±5 
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Table 1: Formulae of piroxicam fast dissolving tablets employing starch crotonate 
Ingredients (mg/tablet) F1 F2 F3 F4 F5 F6 F7 F8 
Piroxicam 20 20 20 20 20 20 20 20 
Starch Crotonate --- 10 --- 10 ---  10 --- 10 
Croscarmellose sodium --- --- 10 10 --- --- 10 10 
Crospovidone --- --- --- --- 10 10 10 10 
Mannitol 172 162 162 152 162 152 152 142 
Microcrystalline cellulose 100 100 100 100 100 100 100 100 
Talc 4 4  4 4 4 4 4  4 
Magnesium stearate 4 4 4 4 4 4 4 4 
Total weight of tablet(mg) 300 300 300 300 300 300 300 300 
 
Friability  
The friability of tablets was measured using a roche friabilator. 
Tablets have been rotated at 25 rpm for 4 min or up to 100 
revolutions. After the removal of fines, the tablets were reweighed 
and the percentage of weight loss was calculated [17]. 
F = X 100 
Drug content uniformity 
For content uniformity test, ten tablets were weighed and powdered 
a quantity of powder equivalent to 10 mg of Piroxicam was extracted 
and filtered into a 0.1N HCL buffer The piroxicam content was 
determined by spectrophotometrically measuring the absorbance at 
242 nm after proper dilution with 0.1 N HCL buffer [17]. 
Wetting time 
The tablet wetting time was measured using a very simple process. 
Five circular tissue papers with a diameter of 10 cm were placed in a 
petri dish with a diameter of 10 cm. Ten ml of water containing a 
water soluble dye (Amaranth) was added to the petri dish. The 
tablet was carefully placed on the surface of the tissue paper. The 
time taken for the water to hit the upper surface of the tablet was 
reported as the wetting time [17]. 
Water absorption ratio 
A piece of tissue paper folded twice was placed in a small petri dish 
with 6 ml of water. The tablet was put on the tissue paper and 
permitted to be fully wet. The wet tablet was then weighed [17]. Water 
absorption ratio, R was calculated by using the following equation 
R=  
Where, Wa = Weight of tablet after water absorption, Wb = Weight of 
tablet before water absorption. 
In vitro disintegration time 
Disintegration time for FDTs was determined using a USP 
disintegration device with a 0.1 N HCL buffer. The medium volume 
was 900 ml and the temperature was 37±0.2 0C. The time taken for 
complete disintegration of the tablet without any palatable mass 
remaining in the apparatus was measured in sec [17]. 
In vitro dissolution rate studies  
In vitro Dissolution Rate Study of Piroxicam Fast Dissolving Tablets 
must have been performed using an 8-station dissolution test device 
(ElectrolabTDT-08L) fitted with paddles (50 rpm) at 37±0.50 C, 
using a 0.1 N HCL buffer (900 ml) as dissolution media. At fixed time 
intervals, 5 ml samples were collected, purified via a 0.45 μ 
membrane filter, diluted and measured at 242 nm using a UV/Visible 
Double Beam Spectrophotometer (Analytical Technology T360).  
Cumulative percentage of drug release was calculated using the 
standard calibration curve absorbance. All dissolution experiments 
have been conducted in triplicate (n=3) [17]. 
Optimization technique 
The optimization technique provides both a scope of knowledge and 
an ability to analyse and define sets of formulation and processing 
variables for a reasonable approach to choosing a variety of testing 
and manufacturing measures for a specific substance for 
quantitative evaluation. At this stage optimization will become a 
valuable method for quantifying a qualitatively defined formulation. 
The present investigation wants to focus on an attempt to follow a 
systematic formulation approach to the optimisation of fast-
dissolving piroxicam tablets using starch crotonate, starch sodium 
glycolate and Crospovidone as superdisintegrants. 
RESULTS AND DISCUSSION 
The starch crotonate prepared was found to be a fine, free-flowing 
amorphous powder. The physical and micromeritic properties of 
starch crotonate were summarized in table 2. Insoluble in aqueous 
solvents and insoluble in organic solvents measured (methanol, 
petroleum ether, dichloromethane and chloroform) the pH of 0.1% 
of the aqueous dispersion was 3.84. 
Starch crotonate had a strong swelling in the bath. The swelling index 
was 50%of all the micrometric properties suggested strong flow and 
compressibility required for the solid dose of the manufacturing cycle. 
The starch crotonate density was found to be 0.66 g/cc. The FTIR of 
starch and crotonate starch was shown in fig. 1, 2. 
The presence of peak absorption at the characteristic ester peak was 
therefore concluded from FTIR studies that starch crotonate (ester) 
was formed when starch was allowed to react with formic acid. X-
ray diffraction pattern.  
As starch crotonate was amorphous and had all the characteristics of 
superdisintegrant, it was hypothesized that starch crotonate may be 
used as a novel superdisintegrant in the formulation of fast-dissolving 
tablets. 
Drug–excipients compatibility studies 
Compatibility of starch Crotonate with the selected drug (Piroxicam) 
was evaluated in the FTIR studies. and Piroxicam–starch Crotonate 
was shown in fig. 3 and 4. The test of FTIR therefore showed that 
there was no association between the chosen medication and the 
new superdisintegrant starch crotonate. As a result, starch crotonate 
may be used as a superdisintegrant in the formulation of fast-
dissolving tablets of the selected medication. 
Evaluation of tablets 
Hardness 
The hardness of the tablets varied from 3.6 to 4 kg/cm2. It implies 
high resilience and the potential to withstand both physical and pre-
functional stress while handling. The hardness of the tablets was 
more when compared to the tablets i. e 3.5 kg/cm2 prepared 
according to S. Jaya, et al. [18]. 
Friability 
By performing friability test to all the optimized formulations the 
weight loss was found to be less than 0.15% indicating good 
mechanical resistance of tablets. Thus, it was proved that tablets 
could withstand the pressure, mechanical shocks during handling, 
transportation, storage and manufacturing processes. The friability 
results were better when compared with the tablets i. e less than 1% 
prepared according to Raha Khalid Dhahir, et al. [19]. 
Drug content 
All of the fast-dissolving tablets prepared included Piroxicam with 
100±5% of the branded argument which was higher in comparison 
to the tablets with drug content 99.01%, prepared according to 
Prashant Bhide, et al. [20]. 
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Table 2: Physical and micromeritic properties of the starch crotonate prepared 
Parameters Observation 
Solubility Insoluble in all aqueous and organic solvents tested 
pH(1% w/v aqueous dispersion) 3.84±0.01 
Melting Point Charred at145 °C±0.01 °C 
Viscosity(1% w/v aqueous dispersion) 1.35±0.01cps 
Swelling index 50%±0.02% 
Gelling property No gelling and the swollen particles of starch crotonate separated from water. Where as in the case of 
starch, it was gelatinized and formed gel. 
Particle Size 149 µm±1.654(80/120mesh) 
Density 0.66±0.0006 g/cc 
Bulk Density 0.57±0.04 g/cc 
Angle of Repose 29.59 °±0.01 
Compressibility Index 13.63±0.02 % 
*SD Standard Deviation from mean, n=3, mean±SD 
 































































































































Fig. 1: FTIR spectra of potato starch 
 













































































































































































































Fig. 2: FTIR spectra of starch crotonate 
Rada et al. 
Int J App Pharm, Vol 13, Issue 4, 2021, 247-256 
251 































































































































































 Page 1/1  
Fig. 3: FTIR spectra of piroxicam pure drug 
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Fig. 4: FTIR Spectra of piroxicam with starch crotonate 
 
In vitro wetting period and water absorption ratio 
Have been found to be below the defined limitations and the 
requirements for fast-dissolving tablets must be followed (fig. 3). In 
vitro wetting time in F8 was smaller i. e 74±0.37 sec, consisting of a 
mixture of 10% starch crotonate, 5% sodium starch glycolate and 
5% cross-crospovidone. This was shown in fig. 5. The wetting time 
was less in comparison to the tablets having wetting time of 76.4 sec 
which were prepared according to A. S. Panwar, et al. [21]. 
In vitro disintegration time 
As mentioned in the table no. 3, the disintegration time of all 
formulated tablets was laid between 18.0±03 to 66±03 sec with 
optimised formulation F8 having 18±03 sec which was relatively 
less when compared to the tablets with disintegration time of 
47.44±2.49 sec, prepared according to Nani Parfati, et al. [22]. 
In–vitro dissolution studies 
From in vitro dissolution studies of fast dissolving tablets containing 
Piroxicam employing starch crotonate, their profile was shown in fig. 
6 and 7. The dissolution data and parameters of all the formulations 
i.e., F-1 to F-8 were given in table no. 4 and 5. K1 had also improved 
in all formulations Similar to the model for F1. The number of folds 
decreased by 10% and the number of folds decreased by 10%. The 
number of folds decreased by k1(min-1) was shown in table 5. It has 
been concluded from the Results that Crotonate starch (new 
superdisintegrant) should be used as a superdisintegrant in the 
formulation of fast-dissolving Piroxicam tablets. The amount of drug 
release in optimised formulation F8 was wound to be 99.83% in 10 
min which is comparatively more in comparison to the tablets 
having 92.46% release in 1 hr, which were prepared according to G. 
B Preeti, et al. [23]. 
 
Rada et al. 
Int J App Pharm, Vol 13, Issue 4, 2021, 247-256 
252 












Water absorption ratio 
(%)±SD 
F1 3.7±0.02 0.12±0.015 19.11±0.33 66±03 140±0.18 27.58±0.01 
F2 4.0±0.01 0.13±0.012 27.39±0.47 32±02 174±0.65 86.20±0.01 
F3 3.9±0.05 0.14±0.015 48.85±0.18 19±05 49.92±0.11 96.66±0.04 
F4 3.6±0.02 0.11±0.014 97.72±0.56 24±04 65±0.88 93.10±0.06 
F5 3.6±0.01 0.12±0.011 28.52±0.44 20±02 55.46±0.42 57.69±0.31 
F6 3.7±0.04 0.14±0.012 88.66±0.63 19±05 57.14±0.19 123.07±0.33 
F7 4.0±0.02 0.15±0.013 37.70±0.45 22±01 51.84±0.21 100±0.52 
F8 3.9±0.01 0.12±0.012 99.33±0.71 18±03 74±0.37 113.7±0.21 
*SD Standard Deviation from mean, n=3, mean±SD 
 
 F1 piroxicam fast dissolving tablet  F2 piroxicam fast dissolving tablet 
        
At T = Zero   At T =140 sec   At T = Zero   At T =174 sec. 
 F3 Piroxicam Fast Dissolving Tablet   F4 Piroxicam Fast Dissolving Tablet  
        
 At T = Zero   At T =49.92 sec   At T = Zero  At T =65 sec 
 F5 piroxicam Fast Dissolving Tablet  F6 piroxicam Fast Dissolving Tablet  
        
 At T = Zero   At T=55.46 sec  At T = Zero  At T = 57.14 sec 
 F7 piroxicam Fast Dissolving Tablet  F8 piroxicam Fast Dissolving Tablet 
        
 At T=Zero   At T =51.84 sec  At T = Zero   At T =74 sec 
Fig. 5: Wetting times of piroxicam fast dissolving tablets formulated by direct compression employing starch crotonate (A novel 
superdisintegrant) and other known superdisintegrants 
 
Table 4: Dissolution data of piroxicam fast dissolving tablets employing starch crotonate and other known superdisintegrants 
Cumulative percent piroxicam released 
Time (min)  F1  F2  F3  F4  F5  F6  F7  F8 
5 11.18±0.22 74.59±0.87 95.83±0.44 96.81±0.13 96.32±0.41 96.81±0.14 98.27±0.19 99.99±10 
10 22.86±0.53 90.72±0.17 99.24±0.61 99.75±0.37 99.27±0.43 99.72±0.58 99.24±0.30 ---- 
15 24.32±0.67 99.91±0.27 ---- ---- ---- ---- ---- ---- 
30 33.56±0.32 ---- ---- ---- ---- ---- ---- ---- 
45 37.81±0.11 ---- ---- ---- ---- ---- ---- ---- 
*SD Standard Deviation from mean, n=3, mean±SD 
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Fig. 7: Dissolution profiles of piroxicam fast dissolving tablets employing starch crotonate and other known superdisintegrants (F5-F8). 
n=3, mean±SD 
 
Table 5: Dissolution parameters of piroxicam fast dissolving tablets formulated employing starch crotonate and other superdisintegrants 
Parameters  F1  F2  F3  F4  F5  F6  F7  F8 
PD10 22.86 90.72 99.24 99.75 99.27 99.72 99.24 99.83 
T50(min)  68.35 4.91 3.48 3.44  3.46  3.44  3.40  3.4 
DE10(%)  21  97.7  93  92.8  93  93.3  93.7  49.9 
Increase in DE10(%)No of folds. --- 0.21 1.05 1.00 0.99 0.99 0.99 1.87 
K1 (min-1) 0.0027 0.0084  0.0047 0.016 0.0059 0.036 0.052 0.133 
Increase in k1(min-1) No of folds ---  0.32  1.78  0.29  2.71  0.16  6.92  0.39 
*SD Standard Deviation from mean, n=3, mean±SD, PD10-Percent dissolved in 10 min, DE10%-Dissolution efficiency in 10 min 
 
The disintegration time and percentage released in 10 min indicates 
that the dependent variables were strongly dependent on 
independent variables. The equipped equations linking the 
disintegration period percent release at the end of 10 min to the 
transform factors were shown in equations. 
Final equation for coded factors 
Disintegration time =+27.50+4.25A-6.75B-
7.75C+4.50AB+3.00AC+7.00BC-5.25ABC. (R2 = 1.000)  
Percent release in 10 min =+80.08+8.62A+14.32B+14.22C-8.37AB-
8.37AC-13.17BC+8.17ABC. (R2 = 1.000) 
The meaning of the R2 shows the right suit. Polynomial calculations 
can be used to draw an inference by evaluating the size of the 
variable and the statistical meaning it bears (positive or negative). 
One can easily deduce from polynomial equations that factor A, B, C 
had a negative effect on the disintegration time of Piroxicam fast-
dissolving tablets. The relations between AB, BC and AC have a 
favourable impact on the rate of disintegration. 
From the polynomial equations one can easily deduce that the factor 
A, B, C had negative effect on the disintegration time of Piroxicam 
fast dissolving tablets. The interactions of AB, BC and AC have 
positive effect on the disintegration time. The relationship of ABC 
had a negative disintegration time. Except for the interaction of AB 
and AC, all other main interactions have a positive effect on the 
percentage produced in 10 min. 
Once the polynomial equation, which compares the rates of each 
component and their subsequent correlations with the time of 
disintegration and the percentage of release in 10 min, the surface 
response curves and contour plots were developed using software.
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(B) Counter plot       (A) Response plot 




(A)Response plot       (B) Counter plot 




(A) Response plot       (B) Counter plot 




(A) Response plot       (B) Counter plot 
Fig. 11: (A) Response plot, (B) Contour plot of piroxicam fast dissolving tablets (effect of starch crotonate and sodium starch glycolate on 
percent dissolved in 5 min) 
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(A) Response plot       (B) Counter plot 
Fig. 12: (A) Response plot, (B) Contour plot of piroxicam fast dissolving tablets (effect of starch crotonate and crospovidone on percent 
dissolved in 5 min) 
 
 
(A) Response plot       (B) Counter plot 
Fig. 13: (A) Response, (B) Contour plot of Piroxicam Fast dissolving tablets (effect of Sodium starch Glycolate and Crospovidone on 
percent dissolved in 5 min) 
 
Response surface plots and contour plots show that as the 
concentration of starch crotonate (A), Crosscarmellose sodium (B), 
Crospovidone (C) increases, the time to disintegrate decreases. The 
effects of A and B on the time of disintegration were shown in fig. 5.6. 
Contour plots have been found to be linear up to a certain degree, 
and there have been non-linear plots thereafter. It was determined 
from the contour plot (fig. 5.6) that less disintegration time can be 
achieved with a level range between 9 and 10 percent and a level of 
B between 4 and 5 percent. The influence of B and C was shown in 
fig. 5.7. The contour plots were found to be a liner that indicates a 
linear relationship between B and C. 
It was determined from the contour plot (fig. 5.7) that less 
disintegration time can be achieved with the B level between 3 to 4 
% and the C level between 3 and 4 %. The effects of A and C were 
shown in fig. 5.8. Contour plots were almost found to be linear, 
indicating a linear relationship between A and C. 
It was calculated from the contour plot that less disintegration time can 
be accomplished with A at between 9 and 10% and C at between 3 and 
4%. As a result, we can conclude that less disintegration time can be 
obtained when factor (A) was used in a concentration range of 9 to 10%. 
B and C in the range from 3 to 4 percent of the overall tablet weight. 
The surface response plot and contour plots indicate that as the 
accumulation of A, B, C increases, the release rate decreases in 10 
min. The impact of A and B on the percent release in 10 min was 
shown in fig 5.9. Contour plots have been found to be linear to a 
certain extent. 
It was calculated from contour plot fig. 5.9 that more percent release 
can be done in 10 min with A range between 9 and 10 %and B level 
between 4 and 5 %. The results of both B and C were shown in fig. 
5.10. Contour plots have been found to be linear, indicating the 
linear relationship between B and C. 
It was calculated from the contour plot fig. 5.10 that more percent 
release in 10 min can be accomplished with a B level range of 
between 4 and 5 % and a B level range of between 4 and 5 %. The 
results of A and C were seen in fig. 5.11. Contour plots have been 
found to be linear, indicating the linear relationship between A 
and C. 
CONCLUSION 
The prepared starch crotonate was found to be fine, free flowing and 
amorphous powder. Also, its physical and micromeritic properties 
were analysed, which indicated good flow and compressibility 
properties that were required for a solid dosage form to be 
manufactured there by fulfilling all the aspects of superdisintegrant 
characteristics. Hence starch crotonate; a novel superdisintegrant 
can be used as a superdisintegrant in the formulation of fast 
dissolving tablets. 
From the above data, the superdisintegrants that to be used in fast 
dissolving tablets with less disintegration time and more dissolution 
efficiency in 10 min were; factor-A i.e., Starch crotonate 10%, factor-
B i.e., Sodium starch glycolate 5% and factor-C i.e., Crospovidone. 
These were found to be the ideal concentrations to formulate into 
fast dissolving tablets. 
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ABBREVIATION 
M–Molar, NaOH–Sodium Hydroxide, °C-Degree Centigrade, #-
Number, pH-Potential of hydrogen, ml-millilitre, g–grams, S. I-
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